Agonists activators antagonists and inhibitors

5740 results for Agonists activators antagonists and inhibitors

Clear allDone

Filters

Product types

Research areas

Target / Protein

Biological action

Chemical type

Product subtype

Filtered by

Filters

Clear all
Show more Hide

GABA and Glutamate Antagonists Kit (ab120376)

Description:
Kit of GABA and Glutamate antagonists

Ionotropic Agonists Kit (ab120323)

Description:
Kit of agonists, antagonists and potentiators at AMPA, Kainate and NMDA receptors

mGlu Agonists Kit (ab120321)

Description:
Kit of mGlu receptor agonists

mGlu Antagonists Kit (ab120322)

Description:
Kit of mGlu receptor antagonists
Product image

Dynamin Inhibitors Toolbox (ab120468)

Specific References (4)
Description:
Dynamin inhibitor kit from the MiTMAB™, Dynole™ and Iminodyn™ chemical series

QVD-OPh Negative control, caspase inhibitors (ab141389)

Description:
Negative control for potent broad spectrum caspase inhibitor
Purity:
> 95%
Product image

Dynamin Inhibitors: Dynole™ Series Kit (ab120474)

Specific References (2)
Description:
Dynamin Inhibitors: Dynole™ Series Kit
Product image

Dynamin Inhibitors: MiTMAB™ Series Kit (ab120473)

Description:
Dynamin Inhibitors: MiTMAB™ Series Kit
Product image

Pentoxifylline, Phosphodiesterase and cytokine inhibitor (ab120725)

Specific References (2)
Description:
Phosphodiesterase inhibitor. Cytokine inhibitor.
Purity:
> 99%
Product image

PD 173074, FGFR1 and FGFR3 inhibitor (ab141117)

Specific References (1)
Description:
Potent FGFR1 and FGFR3 inhibitor
Purity:
> 99%
Product image

GANT 61, GLI1 and 2 inhibitor (ab120904)

Specific References (2)
Description:
Selective GLI1 and 2 inhibitor
Purity:
> 98%
Product image

Honokiol, anti-inflammatory and chemotherapeutic agent (ab120647)

Description:
Anti-inflammatory and chemotherapeutic agent
Purity:
> 98%

Luteolin, Antioxidant and anti-inflammatory (ab120662)

Specific References (1)
Description:
Antioxidant, anti-inflammatory, anticancer flavonoid
Purity:
> 99%

SU-5402, VEGFR and FGFR inhibitor (ab141368)

Specific References (1)
Description:
Potent, selective VEGFR and FGFR inhibitor
Purity:
> 97%

Afatinib (BIBW 2992), Her2/ErbB 2 and EGFR kinase inhibitor (ab142018)

Description:
Potent, irreversible Her2/ErbB 2 and EGFR kinase inhibitor
Purity:
> 99%

Lestaurtinib, JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor (ab142107)

Specific References (1)
Description:
Potent JAK2, FLT3 and TrkA receptor tyrosine kinase inhibitor
Purity:
> 98%

U-51605, PGI2 and TXA2 synthase inhibitor (ab120908)

Specific References (1)
Description:
Selective PGI2 and TXA2 synthase inhibitor. PGH2 analog.
Purity:
> 98%

BMS-599626 (AC480), HER1 and HER2 inhibitor (ab142063)

Description:
Selective HER1 and HER2 inhibitor
Purity:
> 99%

Canertinib (CI-1033), EGFR and HER2/ErbB2 tyrosine kinase inhibitor (ab141402)

Description:
Potent irreversible EGFR and HER2/ErbB2 tyrosine kinase inhibitor
Purity:
> 99%

XL-880 (Foretinib), HGFR and VEGFR2 inhibitor (ab142022)

Description:
Potent ATP-competitive HGFR and VEGFR2 inhibitor
Purity:
> 98%
Sign up